September 2024
September 21, 2024
Increase in Insulin Prices in the U.S. Leads to Federal Case Against Three Major Intermediary Companies
The FTC has filed a lawsuit against three major pharmaceutical intermediaries for allegedly driving up insulin prices and removing lower-cost options from insurance coverage. This…